Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Morgane Denis"'
Hematopoiesis post anti-CD117 monoclonal antibody treatment in wild-type and Fanconi anemia settings
Autor:
Morgane Denis, Leah Swartzrock, Hana Willner, Quenton R. Bubb, Ethan Haslett, Yan Yi Chan, Anzhi Chen, Mark R. Krampf, Agnieszka D. Czechowicz
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Anti-CD117 monoclonal antibody (mAb) agents have emerged as exciting alternative conditioning strategies to traditional genotoxic irradiation or chemotherapy conditioning for both allogeneic and autologous gene-modified hematopoietic stem cell transp
Externí odkaz:
https://doaj.org/article/2c1acddebd3244a0b45e4ce8ebeb255a
Autor:
Kamel Chettab, Chantel Fitzsimmons, Alexey Novikov, Morgane Denis, Capucine Phelip, Doriane Mathé, Pierre Antoine Choffour, Sabine Beaumel, Eric Fourmaux, Patrick Norca, David Kryza, Anne Evesque, Lars Petter Jordheim, Emeline Perrial, Eva-Laure Matera, Martine Caroff, Jerome Kerzerho, Charles Dumontet
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Bacterial lipopolysaccharides (LPS) are potent innate immunostimulants targeting the Toll-like receptor 4 (TLR4), an attractive and validated target for immunostimulation in cancer therapy. Although LPS possess anti-tumor activity, toxicity issues pr
Externí odkaz:
https://doaj.org/article/117d1de624a6452abc1b619b93a387d8
Autor:
Morgane Denis, Doriane Mathé, Manon Micoud, Pierre-Antoine Choffour, Chloé Grasselly, Eva-Laure Matera, Charles Dumontet
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
IntroductionThe use of tumor subcutaneous (SC) implantations rather than orthotopic sites is likely to induce a significant bias, in particular, in the field of immunotherapy.MethodsIn this study, we developed and characterized MC38 models, implanted
Externí odkaz:
https://doaj.org/article/cb90329426364a2a8a5630b099fe97e5
Autor:
Charles Dumontet, Gaëlle Martin, Chloé Beuraud, Yacine Cherifi, Alexandre Fraichard, Patricia Isnard-Petit, Kader Thiam, Angus Sinclair, Poonam Yakkundi, Florence Renart-Depontieu, Morgane Denis, Léa Magadoux, Elsa Kress, Ludovic Bourre, Dean Campbell, Astrid Doerner
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/00408d1699fb42e5a64148ab9eec5e16
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Following the administration of immune checkpoint inhibitors, an unexpected pattern of response designated as hyperprogression may be observed in certain patients. This paradoxical response corresponds to an acceleration in tumor growth and a dramati
Externí odkaz:
https://doaj.org/article/2148cbede5584b68ae3df6c7c7570996
Autor:
Chloé Grasselly, Morgane Denis, Aurore Bourguignon, Nolan Talhi, Doriane Mathe, Anne Tourette, Laurent Serre, Lars Petter Jordheim, Eva Laure Matera, Charles Dumontet
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
In spite of impressive response rates in multiple cancer types, immune checkpoint inhibitors (ICIs) are active in only a minority of patients. Alternative strategies currently aim to combine immunotherapies with conventional agents such as cytotoxic
Externí odkaz:
https://doaj.org/article/bf272d7ef5c84fddaf27c5badc894146
Publikováno v:
Inorganic Chemistry. 61:9308-9317
Interest in coordination compounds based on non-innocent ligands (NILs) for electrochemical energy storage has risen in the last few years. We have focused our attention on an overlooked redox active linker, croconate violet, which has not yet been a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::559144f6520001149627014a3ed16514
https://doi.org/10.1021/acs.inorgchem.2c01043
https://doi.org/10.1021/acs.inorgchem.2c01043
Autor:
Charles Dumontet, Eva-Laure Matera, Christian Klein, Lars Petter Jordheim, Elsa Kress, Fabian Birzele, Aurore Bourguignon, Nolan Talhi, Anne Tourette, Kamel Chettab, Doriane Mathé, Anne Wierinckx, Pierre-Antoine Choffour, Chloé Grasselly, Morgane Denis
Supplementary Data from In Vivo Syngeneic Tumor Models with Acquired Resistance to Anti–PD-1/PD-L1 Therapies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c1d470b26a064a247545c2063ac39c1
https://doi.org/10.1158/2326-6066.22545206.v1
https://doi.org/10.1158/2326-6066.22545206.v1
Autor:
Charles Dumontet, Eva-Laure Matera, Christian Klein, Lars Petter Jordheim, Elsa Kress, Fabian Birzele, Aurore Bourguignon, Nolan Talhi, Anne Tourette, Kamel Chettab, Doriane Mathé, Anne Wierinckx, Pierre-Antoine Choffour, Chloé Grasselly, Morgane Denis
Antibodies targeting PD-1 and PD-L1 have produced durable responses in a subset of patients with cancer. However, a majority of these patients will ultimately relapse due to acquired resistance. To explore the underlying mechanisms of this secondary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94f888b755b1943311e115d6c0ed7178
https://doi.org/10.1158/2326-6066.c.6550883.v1
https://doi.org/10.1158/2326-6066.c.6550883.v1
Autor:
Morgane Denis, Hubert Chevreau, Pablo Salcedo-Abraira, Philippe Moreau, Nicolas Dupré, Michael Paris, Philippe Poizot, Thomas Devic
Publikováno v:
Molecular Systems Design & Engineering.
MIL-53(M)-(OH)2 (M = Al, Fe) solids based on a redox active dioxoterephthalate ligand were lithiated post-synthesis, and the resulting products were evaluated as positive electrode materials for Li-ion batteries.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c244f2d71ea7a223ca0dca9c932daf7
https://doi.org/10.1039/d3me00030c
https://doi.org/10.1039/d3me00030c